P38 Mitogen-activated Protein (Map) Kinase Inhibitor (SB-681323)Study In Patients With Neuropathic Pain

NCT00390845 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain, Neuropathic

Interventions

DRUG: SB681323
DRUG: Placebo

Sponsor

GlaxoSmithKline